Translation Inhibition through eIF4A1 Targeting in Multiple Myeloma Is a Promising Therapeutic Strategy

被引:0
|
作者
Dutrieux, Laure [1 ]
Loughran, Elle [2 ,3 ]
Choquet, Armelle [4 ]
Herault, Helene [4 ]
Guillemin, Antoine [1 ]
Robert, Nicolas [5 ]
Requirand, Guilhem [5 ]
Cartron, Guillaume [6 ,7 ,8 ]
Vincent, Laure [9 ]
Herbaux, Charles [10 ,11 ,12 ]
Rivals, Eric [2 ]
David, Alexandre [4 ]
Moreaux, Jerome [1 ,5 ,12 ,13 ,14 ,15 ,16 ]
机构
[1] Inst Genet Humaine, Montpellier, France
[2] LIRMM, Montpellier, France
[3] Trin Coll, Dublin, Ireland
[4] Inst Genet Fonctionnelle, Montpellier, France
[5] Montpellier Univ Hosp Ctr, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France
[6] Montpellier Univ Hosp Ctr, Dept Biol Hematol, Montpellier, France
[7] Montpellier Univ Hosp Ctr, Clin Hematol Dept, Montpellier, France
[8] Univ Montpellier, IGMM UMR 5535 CNRS UM, Montpellier, France
[9] Montpellier Univ Hosp Ctr, Dept Clin Hematol, Montpellier, France
[10] Univ Montpellier, Fac Med, Montpellier, France
[11] Montpellier Univ Hosp, Dept Clin Hematol, Montpellier, France
[12] Univ Montpellier, CNRS UMR, Inst Human Genet, Montpellier, France
[13] Univ Med, Fac Med, Montpellier, France
[14] Inst Univ France, Paris, France
[15] Montpellier Univ Hosp, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France
[16] Univ Montpellier, Montpellier, France
关键词
D O I
10.1182/blood-2023-184749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Targeting of eIF4A1 curtails lung metastases in triple-negative breast cancer
    Sridharan, Sangita
    Srivastava, Shobhit
    Terrero, David
    Malla, Saloni
    Tiwari, Amit K.
    Raman, Dayanidhi
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma
    Manier, Salomon
    Huynh, Daisy
    Shen, Yu J.
    Zhou, Jia
    Yusufzai, Timur
    Salem, Karma Z.
    Ebright, Richard Y.
    Shi, Jiantao
    Park, Jihye
    Glavey, Siobhan V.
    Devine, William G.
    Liu, Chia-Jen
    Leleu, Xavier
    Quesnel, Bruno
    Roche-Lestienne, Catherine
    Snyder, John K.
    Brown, Lauren E.
    Gray, Nathanael
    Bradner, James
    Whitesell, Luke
    Porco, John A., Jr.
    Ghobrial, Irene M.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (389)
  • [23] Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma
    Bruyer, Angelique
    Dutrieux, Laure
    de Boussac, Hugues
    Martin, Thibaut
    Chemlal, Djamila
    Robert, Nicolas
    Requirand, Guilhem
    Cartron, Guillaume
    Vincent, Laure
    Herbaux, Charles
    Lutzmann, Malik
    Bret, Caroline
    Pasero, Philippe
    Moreaux, Jerome
    Ovejero, Sara
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] miR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1
    Cao, Wenlong
    Wei, Weiyuan
    Zhan, Zexu
    Xie, Yubo
    Xiao, Qiang
    ONCOLOGY REPORTS, 2016, 35 (05) : 2583 - 2591
  • [25] Targeting iron homeostasis in combination with IMiDs as a therapeutic strategy in multiple myeloma
    Ovejero, Sara
    Devin, Julie
    Caneque, Tatiana
    Henry, Laura
    Alibert, Laura
    Requirand, Guilhem
    Robert, Nicolas
    Steer, Alizee
    Machura, Amelie
    Hirtz, Christophe
    Bruyer, Angelique
    Vincent, Laure
    Cartron, Guillaume
    Herbaux, Charles
    Rodriguez, Raphael
    Bret, Caroline
    Moreaux, Jerome
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S149 - S149
  • [26] Targeting CD47 As a Novel Therapeutic Strategy in Multiple Myeloma
    Muz, Barbara
    Kusdono, Hubert D.
    King, Justin
    Kohnen, Daniel
    Fiala, Mark A.
    Vij, Ravi
    Capoccia, Ben
    Manning, Pamela T.
    Salama, Noha Nabil
    Azab, Abdel Kareem
    BLOOD, 2017, 130
  • [27] Targeting IRE1α-XBP1 Pathway Is a Novel Therapeutic Strategy In Multiple Myeloma
    Mimura, Naoya
    Hideshima, Teru
    Gorgun, Gullu
    Cirstea, Diana
    Santo, Loredana
    Hu, Yiguo
    Fabre, Claire
    Blumenthal, Martina
    Tam, Victor
    Kertesz, Nathalie L.
    Zeng, Qingping
    Patterson, John B.
    Munshi, Nikhil C.
    Richardson, Paul
    Anderson, Kenneth C.
    BLOOD, 2010, 116 (21) : 1659 - 1659
  • [28] Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma
    Mimura, Naoya
    Fulciniti, Mariateresa
    Gorgun, Gullu
    Tai, Tzu
    Cirstea, Diana
    Santo, Loredana
    Hu, Yiguo
    Fabre, Claire
    Ohguchi, Jiro Minami Hiroto
    Kiziltepe, Tanyel
    Ikeda, Hiroshi
    Kawano, Yutaka
    French, Maureen
    Blumenthal, Martina
    Tam, Victor
    Kertesz, Nathalie L.
    Malyankar, Uriel M.
    Hokenson, Mark
    Pham, Tuan
    Zeng, Qingping
    Patterson, John B.
    Richardson, Paul G.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2012, 119 (24) : 5772 - 5781
  • [29] Blockade of XBP1 Splicing by Inhibition of IRE1α Is a Promising Therapeutic Option in Multiple Myeloma
    Mimura, Naoya
    Fulciniti, Mariateresa
    Gorgun, Gullu
    Tai, Yu-Tzu
    Cirstea, Diana D.
    Santo, Loredana
    Hu, Yiguo
    Fabre, Claire
    Minami, Jiro
    Ohguchi, Hiroto
    Kiziltepe, Tanyel
    Ikeda, Hiroshi
    Kawano, Yutaka
    Blumenthal, Martina
    Tam, Victor
    Kertesz, Nathalie L.
    Hokenson, Mark
    Zeng, Qingping
    Patterson, John B.
    Richardson, Paul G.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2011, 118 (21) : 64 - 65
  • [30] Calpain inhibition: A therapeutic strategy targeting multiple disease states
    Carragher, NO
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (05) : 615 - 638